Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Schizophrenia: a psychobiological view]

M Rodríguez-Arias1, M A Aguilar, R Espert

  • 1Area de Psicobiología, Facultad de Psicología, Universitat de València, España.

Revista De Neurologia
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Jorge Manzanares: posthumous tribute to a great researcher, teacher, and friend.

Adicciones·2026
Same author

Ketamine attenuates the effects of intermittent social defeat on anxiety, social interaction and cocaine-induced conditioned place preference in male mice.

Physiology & behavior·2025
Same author

Intermittent voluntary wheel running promotes resilience to the negative consequences of repeated social defeat in mice.

Physiology & behavior·2022
Same author

Brief Maternal Separation Inoculates Against the Effects of Social Stress on Depression-Like Behavior and Cocaine Reward in Mice.

Frontiers in pharmacology·2022
Same author

Reduced salivary oxytocin after an empathic induction task in Intimate Partner Violence perpetrators: Importance of socio-affective functions and its impact on prosocial behavior.

Psychoneuroendocrinology·2022
Same author

Unravelling the Neuroinflammatory Mechanisms Underlying the Effects of Social Defeat Stress on Use of Drugs of Abuse.

Current topics in behavioral neurosciences·2021

Schizophrenia research is uncovering its causes through genetics and neuroimaging. New drug targets focus on dopamine and neuropeptide interactions for better treatment of this severe mental illness.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Context:

  • Schizophrenia is a major global psychiatric disorder with complex symptoms.
  • Its precise causes have remained largely elusive for decades.
  • Recent advancements in various scientific fields are beginning to illuminate its etiology.

Purpose:

  • To review recent findings on the interactions between opioid and dopaminergic systems in schizophrenia.
  • To explore the role of cortical-striate-thalamic loops in the disorder's pathophysiology and treatment.
  • To examine cognitive and attentional deficits in animal models of schizophrenia.

Summary:

  • Schizophrenia symptoms are linked to dopamine system dysfunction.
  • Current antipsychotics target dopamine D2-receptors, but novel drugs exploring other dopamine and neuropeptide receptors are under investigation.

Related Experiment Videos

  • Opioid-dopaminergic interactions, particularly within cortical-striate-thalamic circuits, offer potential new avenues for understanding and treating schizophrenia.

    • Impact:

    • Advances in understanding schizophrenia's neurochemical basis.
    • Identification of novel therapeutic targets beyond traditional dopamine antagonism.
    • Improved insights into cognitive deficits and potential treatments through animal models.